STAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug
· statnews.com · popularity 34/100 · 0 similar stories today · Pharmaceuticals & Medical Research (Health & Life Sciences)
Read the original at statnews.com →
Summary
Ionis Pharmaceuticals lost more than $1 billion in market value on Monday after the company slashed sales projections for a triglyceride-lowering drug.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 1.